Parmax Pharma's Stock Receives 'Hold' Call from MarketsMOJO.

Parmax Pharma, a microcap pharmaceutical company, has been making headlines in the stock market recently. The company's stock, which is currently trading at a price of 32.9, has been given a 'Hold' call by MarketsMOJO. This comes after the stock reached a high of 35.8, but has since fallen after two consecutive days of gains.

In terms of performance, Parmax Pharma is in line with the overall sector, showing a trend reversal after two days of consecutive gains. The stock is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend.

In comparison to the Sensex, Parmax Pharma's 1-day performance is slightly lower at -0.30% while the Sensex has shown a 0.25% increase. However, this does not necessarily reflect the overall performance of the company, as stock prices can fluctuate on a daily basis.

As a microcap company in the pharmaceutical industry, Parmax Pharma has been steadily making progress and gaining attention in the stock market. With a 'Hold' call from MarketsMOJO, investors may want to keep an eye on this company's future developments.